RxDoctor Payments Data

Thomas McDonald, MD

Foot and Ankle Surgery · Enfield, CTNPI 1639139868

Payments from drug & device makers

What this record shows

The money is spread across several categories — royalties or licence payments (52.5%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by Medartis Inc. at 52.5% of the total. Reporting peaked in 2024 at $166,335 and has fallen 70.2% since, to $49,600 in 2025. Among foot and ankle surgery clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$240,511in general payments, 2019–2025

Across 134 payments — averaging $1794.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medartis Inc.$126K
  • Novastep Inc.$48K
  • Medshape, Inc.$16K
  • Trilliant Surgical LLC.$16K
  • Encore Medical, LP$7K
  • Acumed LLC$6K
  • plus $22K from 21 others
$1,118in ownership & investment interests, 2019–2025

Across 1 payment — averaging $1117.81 each. An ownership or investment interest held by the physician or an immediate family member.

  • Oxford Performance Materials, Inc.$1K

What the payments were for

  • Royalty or licence$126,25552%
  • Consulting fees$89,90737%
  • Speaking & faculty fees$1750%
  • Travel & lodging$16,3367%
  • Food & beverage$5,2392%
  • Education$2,5051%
  • Gifts$940%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$240,511 in reported general payments places this provider in the 95th percentile of 89 foot and ankle surgery providers in Connecticut.

See all foot and ankle surgery providers in Connecticut

Medicare billing

Part B allowed, 2024
$154,462
Medicare patients
275
Services billed
1,369

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin48$273
Celecoxib19$235
Methocarbamol12$109
Meloxicam57$96
Oxycodone Hcl20$82

Paid to pharmacies, not to this prescriber.

Other foot and ankle surgery in Enfield

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →